Oxygen therapy is prescribed to patients with chronic obstructive pulmonary diseases (COPD), one of the most rapid increasing causes of death. The oxygen used can be liquefied or pressurized but is more often generated in place from ambient air with a concentrator unit. Current concentrators have numerous disadvantages, which result in a serious restriction of mobility and poor compliance to therapy. The development of a more comfortable and cost-effective oxygen concentrator method based on novel membrane technology is proposed. The concentrator will be enhanced with pyrometer, sensory, telemetry and medicine-dosing functionality creating possibilities for a whole new concept of oxygen therapy involving dynamic on demand adjusted therapy and telemedicine and monitoring possibilities for the physician. The enhanced oxygen therapy possibilities can improve quality of life of COPD patients by keeping them longer fit and independent.
Funding SchemeEAW - Exploratory awards
1800 BJ Alkmaar